NON SMALL CELL LUNG CARCINOMA NSCLC
Clinical trials for NON SMALL CELL LUNG CARCINOMA NSCLC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CARCINOMA NSCLC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CARCINOMA NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lung cancer drug aims to outperform current standard in advanced disease
Disease control Recruiting nowThis study tests a new medicine called SCTB14 against the standard drug pembrolizumab for people with advanced non-small cell lung cancer that has not been treated yet. About 246 adults with a specific tumor marker (TPS ≥10%) will receive either SCTB14 or pembrolizumab to see whi…
Matched conditions: NON SMALL CELL LUNG CARCINOMA NSCLC
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Cutting chemo doses for seniors: does it shorten lives?
Knowledge-focused Recruiting nowThis study examines whether older patients (65+) with advanced lung cancer who receive lower doses of chemotherapy live as long as those who get standard doses. Researchers will review medical records of 150 patients to compare survival and treatment response. The goal is to help…
Matched conditions: NON SMALL CELL LUNG CARCINOMA NSCLC
Sponsor: University of Malaya • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC